Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Operating Expenses (2016 - 2025)

Surgery Partners (SGRY) has disclosed Operating Expenses for 12 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 207.87% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 billion through Dec 2025, up 33.6% year-over-year, with the annual reading at $2.9 billion for FY2025, 23.24% up from the prior year.
  • Operating Expenses hit $1.0 billion in Q4 2025 for Surgery Partners, up from $715.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.0 billion in Q4 2025 to a low of $340.5 million in Q4 2024.
  • Historically, Operating Expenses has averaged $567.6 million across 5 years, with a median of $527.5 million in 2022.
  • Biggest five-year swings in Operating Expenses: crashed 37.15% in 2024 and later skyrocketed 207.87% in 2025.
  • Year by year, Operating Expenses stood at $495.4 million in 2021, then increased by 5.53% to $522.8 million in 2022, then rose by 3.63% to $541.8 million in 2023, then plummeted by 37.15% to $340.5 million in 2024, then surged by 207.87% to $1.0 billion in 2025.
  • Business Quant data shows Operating Expenses for SGRY at $1.0 billion in Q4 2025, $715.8 million in Q3 2025, and $630.6 million in Q2 2025.